ImmunityBio’s Fortunes Rise with Asian Approval

The company had already benefited from a degree of encouragement, stemming from the recent revision of the National Comprehensive Cancer Network’s clinical guidelines. The inclusion of Anktiva®, in combination with Bacillus Calmette-Guérin, as a suitable treatment for certain bladder cancers unresponsive to simpler remedies, had provided a welcome boost. Now, it appears Macau’s authorities perceive a similar merit in this therapeutic alliance, granting approval for the very same patient cohort. One cannot help but observe that a favourable verdict, even in a smaller sphere, possesses a peculiar power to inspire confidence.

CrowdStrike: A Modestly Priced Hope?

A lot of cybersecurity firms, it turns out, are still shipping around physical boxes. Great hulking machines filled with blinking lights and needing constant attention. It’s a bit like trying to run a modern hospital from a converted Victorian mansion. CrowdStrike, though, has embraced the cloud. Everything lives ‘up there’, which means no boxes, less electricity, and fewer frantic calls to IT when something goes wrong. This, they say, creates a ‘moat’ – a term economists seem particularly fond of. The idea is, it’s harder for competitors to dislodge you if you’ve built a really good, slippery moat. It’s a surprisingly effective metaphor, really. Though I do wonder if they’ve considered alligators.

Viking Therapeutics: A Weighty Proposition

One company currently caught in the delightful chaos is Viking Therapeutics (VKTX +2.23%). They haven’t quite managed to turn lead into gold, or, in this case, a consistently effective drug, but they’re heading in the right direction. And if they do succeed, well, let’s just say the shareholders might require larger carriages.

Oil & Dividends: A Prudent Hunter’s Guide

The modern marvel of fractional shares means even a humble apprentice wizard—or someone with a mere hundred dollars to their name—can acquire a piece of the action. So, let’s examine a few contenders. Not for the thrill of the gamble, but for the quiet satisfaction of a growing income. Think of it as building a small fortress against the inevitable economic blizzards.

Tom Lee’s Wild Ride: 7,700 S&P Target or Just a Financial Fairy Tale?

In a recent chat with CNCB (where else would a market strategist whisper sweet nothings?), Lee proclaimed that his equity research firm, Fundstrat Global Advisors, is as steady as a giant peach floating down a river of uncertainty. “7,700 was a conservative estimate,” he chirped, as if conservatism and stock markets were the best of friends. “Markets are repricing, P/E expansion is modest, and wars? Oh, wars are just a little hiccup before the grand feast of opportunity!”

Goodyear’s Fortunes: A Comedy of Oil

Goodyear’s entanglement with the black, viscous substance is, alas, a double-edged sword. Firstly, a rise in oil’s price invariably leads to a lamentable increase in the cost of conveyance – that is, gasoline. This, in turn, discourages the populace from indulging in leisurely drives, reducing the miles traveled. A grievous blow to those who profit from the replacement of worn tires, for it is upon this necessity that they rely for some 70% of their trade. A most precarious existence, built upon the gradual decay of others’ possessions!

Alibaba: A Cloud with a Silver Lining?

Alibaba’s cloud intelligence division, a surprisingly literal description, managed a 36% growth spurt this quarter. This is, on the face of it, encouraging. However, overall net income experienced a rather precipitous decline – 66%, to be precise. This isn’t necessarily a sign of impending doom (though one should always keep a small emergency raft handy), but rather a consequence of a strategic pivot. A pivot, in this context, involving substantial investment in technology, improved user experiences, and a rather brisk pace of commerce. (One wonders if the commerce is actually brisk, or merely appears brisk due to a cleverly designed illusion of speed. The universe is full of such things.)

Market Volatility & Long-Term Value Preservation

The prevailing tendency to extrapolate immediate events into sustained trends represents a recurring behavioral bias. While geopolitical risk undeniably introduces uncertainty, it is crucial to differentiate between transient disruption and fundamental impairment of underlying economic value. The S&P 500, as a broad market benchmark, has historically demonstrated resilience, recovering from numerous shocks – including, but not limited to, global conflicts, oil crises, and systemic financial events. Attributing outsized weight to current anxieties, therefore, requires careful consideration.

FuboTV: A Streaming Saga (and My Portfolio’s Pain)

They announced a 1-for-12 reverse stock split. Which, let’s be honest, never sounds good. It’s like admitting your trousers no longer fit and needing to buy a smaller size. It’s supposed to keep the share price above a certain level – a sort of financial dignity thing – and attract investors who wouldn’t dream of touching anything below a certain price. Apparently. It feels a bit like rearranging the deckchairs on the Titanic, doesn’t it? Trying to make things look better when the fundamental problem is, well, everything.

Trump’s Tall Tale Sends XRP on a Wild Ride: Iran Calls It Nonsense!

There was old President Trump, standing in front of his cameras, spinning a yarn so grand it could’ve been plucked from one of my own whoppers. He claimed-oh, what a claim!-that Iran had agreed to 15 diplomatic concessions, including a promise to toss their nuclear program into the dustbin. And, as if that weren’t enough, he said he and the Ayatollah would be chummy chums, jointly overseeing oil flow through the Strait of Hormuz. What poppycock!